Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.19%) to 10457.01, DAX (0.16%) to 24155.45, CAC40 +0.87% to 8227.32, STOXX 600 +0.05% to 614.20

Apr 23 ,2026

  • Synopsis:

    • European equity markets mixed at the close. Financials, banks, media the big laggards, while telecom, food/beverage, personal goods/luxury the big outperformers. US equity markets mixed in midday trading. Treasuries mostly weaker with some curve flattening; yields down 1-2 bp at the long end. Dollar index flat. Gold little changed. Silver off 2.0%. Bitcoin futures down 1.0%, but off worst levels. WTI crude up 0.6% in somewhat choppy trading.

    • Tensions over the Strait of Hormuz weighing on risk appetite. Iran seized and fired on commercial ships and US reportedly intercepted Iran-linked tankers in Asian waters, which supported oil prices. While there have been reports of diplomatic progress in recent days, uncertainty is elevated and there are no plans for another face-to-face meeting. Iran insist on US ending blockade first and White House waiting on fractured Iranian leadership to unify behind a position.

    • Economic consequences of a prolonged closure of Strait impacting European equity market sentiment. Brokers turning more cautious on region as Q1 earnings season begin amid Iran war energy shocks. Rising input costs and margin pressure expected to weigh on consumer and industrial sectors if Strait remains closed for an extended period. Banks also tipped to have more cautious outlook with loan demand potentially weakening. Many analysts have cut year-end forecasts for Stoxx 600 as a result.

    • On data front, Eurozone composite PMI contracting for the first time since Nov-24 on big drop in services sector activity. UK PMI surprised on the upside, but number distorted due to Iran conflict. CBI industrial trends survey also weakest since early 2021. In other macro news, European car sales up 11.1% in March as strong appetite for electric vehicles offset a drop in petrol and diesel cars. Latest UK public finance data saw lowest March borrowing in three years. UK consumer confidence readings via GfK and BRC also deteriorated ahead of tomorrow's March retail sales update.

    • Amidst a busy earnings calendar, French names in focus, with Danone (BN.FP), EssilorLuxottica (EL.FP), Sanofi (SAN.FP), STMicroelectronics (STMPA.FP), Orange (ORA.FP), Safram (SAF.FP), L'Oreal (OR.FP), Carrefour (CA.FP), Dassault Systemes (DSY.FP) and Renault (RNO.FP) among few others posting their most recent numbers; in the DACH region, Roche (ROP.SW), Nestle (NESN.SW) (also agreed the sale of Blue Bottle Coffee), Stabilus (STM.GR), Galderma (GALD.SW) and Sartorius (SRT3.GR) updated investors before the open. In the Nordics, Nokia (NOKIA.FH) Q1 core profit beat forecasts and management lifted 2026 guidance toward the top of its range. Elsewhere, London Stock Exchange Group (LSEG.LN), Sainsbury (SBRY.LN), BE Semiconductor Industries (BESI.NA) and Heineken (HEIA.NA) also reported before the open.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Food & Beverage +1.63%, Telecom +1.59%, Persnl & HHold Goods +1.33%, Utilities +0.85%, Oil & Gas +0.66%, Ind Goods & Svcs +0.56%, Basic Resources +0.34%, Health Care +0.22%, Construct & Mtls +0.19%, Chemicals +0.15%

      • Underperformers:

        • Financial Svcs (1.33%), Banks (1.20%), Real Estate (0.92%), Media (0.71%), Technology (0.69%), Retail (0.59%), Insurance (0.37%), Autos & Parts (0.25%), Travel & Leisure (0.18%)

    • Macro:

      • Geopolitics:

        • EU summit in Ayia Napa focuses on energy crisis from Iran war, long-term budget, and regional security amid Hormuz disruptions: FT and Politico

        • EU formally approves €90B loan to Ukraine: Reuters

        • Lithuania backs building military facility at critical NATO site: Bloomberg

      • Economy:

        • Eurozone private sector unexpectedly contracts as services decline amid consumer impact from Iran war: Bloomberg

        • UK PMI surprised on the upside in April after hitting six-month low in March

        • European car sales jump 11.1% in March on strong EV surge; Tesla outpaces BYD as electrified vehicles near 70% of registrations: Reuters

    • Peripheral markets:

      • Switzerland:

        • Swiss government proposes tougher capital rules for UBS post-Credit Suisse, sparking debate on competitiveness and taxpayer protection (Reuters)

      • Norway:

        • Wealth fund assessing whether to invest in SpaceX: Reuters

      • Sweden:

        • Considering ways to cut energy use if Iran war continues: Bloomberg

      • Netherlands:

        • Dutch are facing biggest security threat in decades, intelligence agency says: Reuters

    • Company news:

      • Notable Gainers

        • +19.5% ENEA.SS (Enea AB SEK75.60, +12.40) -- earnings

        • +15.2% HUSQ.B.SS (Husqvarna SEK45.80, +6.05) -- earnings

        • +14.5% AUTO.NO (AutoStore Holdings NOK12.08, +1.53) -- earnings

        • +14.5% STMPA.FP (STMicroelectronics €42.90, +5.45) -- earnings

        • +12.2% RWS.LN (RWS Holdings £0.94, +0.10) -- trading update

        • +11.6% ASC.LN (Asos £2.51, +0.26) -- earnings

        • +11.2% DOM.SS (Dometic Group SEK32.86, +3.32) -- earnings

        • +10.8% VITR.SS (Vitrolife SEK118.50, +11.50) -- earnings

        • +10.4% TYRES.FH (Nokian Renkaat €10.57, +1.00) -- SEB upgrade

        • +9.6% DOM.LN (Domino's Pizza Group £2.01, +0.18) -- trading update

        • +9.1% OR.FP (L'Oreal €376.70, +31.40) -- sales

        • +8.5% HMS.SS (HMS Networks SEK516.50, +40.40) -- earnings

        • +8.4% MIPS.SS (MIPS SEK290.40, +22.40) -- earnings; CFO to step down

        • +7.2% FSKRS.FH (Fiskars €13.40, +0.90) -- earnings

        • +6.6% GALD.SW (Galderma Group CHF159.85, +9.95) -- sales

        • +6.4% PRIC.B.SS (Pricer SEK3.76, +0.23) -- earnings

        • +6.4% BHG.SS (Lightshop SEK24.18, +1.46) -- earnings

        • +6.1% KOG.NO (Kongsberg Gruppen NOK328.10, +18.90) -- Kongsberg Maritime shares begin trading

        • +6.1% HIK.LN (Hikma Pharmaceuticals £14.02, +0.80) -- trading statement

        • +5.9% NESN.SW (Nestle CHF80.06, +4.45) -- sales; agreement to sell Blue Bottle Coffee

        • +5.5% BESI.NA (BE Semiconductor Industries €244.90, +12.80) -- earnings

        • +5.5% NCAB.SS (NCAB Group SEK73.00, +3.80) -- earnings

        • +5.2% STAB1L.GR (Stabilus €17.66, +0.88) -- earnings

        • +4.9% NOKIA.FH (Nokia €8.96, +0.41) -- earnings

        • +4.7% JM.SS (JM SEK122.80, +5.50) -- earnings

        • +4.6% METSO.FH (Metso Corp. €15.41, +0.68) -- Inderes, Handelsbanken upgrades

        • +4.5% FRVIA.FP (Forvia €10.67, +0.46) -- Apollo nearing deal to acquire Forvia's interior unit for €1.4B (~$1.6B) -- Bloomberg

        • +4.5% EDEN.FP (Edenred €21.12, +0.91) -- sales

        • +4.4% SAAB.B.SS (Saab SEK589.60, +25.00) -- earnings

        • +4.3% NORBT.NO (Norbit NOK236.60, +9.80) -- DNB Carnegie upgrade

        • +4.3% EPR.NO (Europris NOK98.90, +4.10) -- earnings

        • +4.2% OBI.LN (Ondine Biomedical £0.13, +0.01) -- Steriwave nasal decolonisation provides notable patient safety results according to University of Ottawa Heart Institute

        • +4.0% ERA.FP (Eramet €54.80, +2.10) -- trading update

        • +3.8% ROP.SW (Roche Holding CHF324.50, +11.80) -- earnings; FDA grants orphan drug designation to Genentech's divarasib

        • +3.7% SVED.B.SS (Svedbergs Group SEK61.40, +2.20) -- earnings

        • +3.7% BUFAB.SS (Bufab SEK122.00, +4.40) -- earnings

        • +3.7% ORA.FP (Orange €17.99, +0.64) -- earnings

        • +3.2% SIP.BB (Sipef €100.20, +3.10) -- Q1 total palm oil production

        • +2.8% GRNG.SS (Gränges SEK165.30, +4.50) -- earnings

        • +2.7% SCHP.SW (Schindler Holding CHF278.20, +7.40) -- earnings

        • +2.7% SAF.FP (Safran €280.00, +7.40) -- sales

        • +2.4% IPN.FP (Ipsen €164.00, +3.90) -- sales

        • +1.8% TEQ.SS (Teqnion SEK160.60, +2.80) -- earnings

        • +1.6% ATRAV.FH (Atria €17.78, +0.28) -- earnings

        • +1.6% ESSITY.B.SS (Essity SEK248.70, +4.00) -- earnings; buyback

        • +1.4% DSY.FP (Dassault Systemes €19.22, +0.27) -- earnings

        • +1.4% EQNR.NO (Equinor NOK354.60, +5.00) -- Norne Securities upgrade

        • +1.3% HEXA.B.SS (Hexagon SEK104.10, +1.30) -- earnings

        • +1.2% HUMBLE.SS (Humble Group SEK7.63, +0.09) -- earnings

        • +1.0% SAN.FP (Sanofi €81.55, +0.77) -- earnings; Dupixent (dupilumab) approved in US

      • Notable Decliners

        • -16.6% BIM.FP (bioMerieux €74.00, -14.75) -- sales

        • -13.2% DIM.FP (Sartorius Stedim Biotech €159.80, -24.20) -- earnings

        • -11.9% HNSA.SS (Hansa Biopharma SEK24.00, -3.22) -- earnings

        • -10.0% VERK.FH (Verkkokauppa.com €2.70, -0.30) -- earnings

        • -10.0% SRT3.GR (Sartorius €212.50, -23.70) -- earnings

        • -9.5% AXFO.SS (Axfood SEK291.30, -30.60) -- earnings

        • -9.1% ZEHN.SW (Zehnder Group CHF67.50, -6.80) -- Kepler Cheuvreux downgrade

        • -8.6% LINC.SS (Linc AB SEK69.80, -6.60) -- earnings

        • -8.3% BRCK.LN (BRCK Group £0.48, -0.04) -- Atlas Holdings will not make an offer; trading update

        • -8.2% EMG.LN (Man Group £2.43, -0.22) -- trading statement

        • -6.8% SMWH.LN (WH Smith £5.86, -0.43) -- earnings

        • -6.7% BEIJ.B.SS (Beijer Ref SEK135.30, -9.70) -- earnings

        • -5.7% AQ.SS (AQ Group SEK216.00, -13.00) -- earnings

        • -5.6% VVY.NA (Vivoryon Therapeutics €1.27, -0.08) -- earnings

        • -5.6% NORION.SS (Norion Bank SEK54.20, -3.20) -- earnings; buyback

        • -4.6% ORNBV.FH (Orion €69.95, -3.35) -- earnings; trial launch

        • -4.6% RATO.B.SS (Ratos SEK33.92, -1.62) -- Kepler Cheuvreux downgrade

        • -4.6% EL.FP (EssilorLuxottica €192.15, -9.35) -- sales

        • -4.2% NOTE.SS (NOTE SEK188.90, -8.30) -- earnings

        • -4.2% CDON.SS (CDON AB SEK67.60, -3.00) -- earnings

        • -4.2% OVZON.SS (Ovzon AB SEK59.90, -2.65) -- earnings

        • -4.2% OLVAS.FH (OLVI €31.00, -1.35) -- earnings

        • -4.0% SBRY.LN (J Sainsbury £3.39, -0.14) -- earnings; buyback

        • -3.7% EXPN.LN (Experian £27.75, -1.07) -- Freddie Mac and Fannie Mae begin accepting VantageScore 4.0

        • -3.2% DNB.NO (DNB Bank NOK280.30, -9.20) -- earnings

        • -3.0% PCELL.SS (PowerCell Sweden SEK23.68, -0.74) -- earnings

        • -2.7% UBSG.SW (UBS Group CHF32.57, -0.92) -- statement on regulatory capital announcements made by Swiss government

        • -2.3% BACTI.B.SS (Bactiguard Holding SEK17.15, -0.40) -- earnings

        • -2.2% RPI.LN (Raspberry Pi Holdings £5.89, -0.13) -- placing

        • -2.2% REL.LN (RELX £26.80, -0.60) -- trading update

        • -1.8% ASML.NA (ASML Holding €1,227.40, -22.80) -- TSMC (2330.TT) says it won't use ASML's latest generation machine until 2029 -- Reuters

        • -1.2% PROT.NO (Protector Forsikring NOK481.80, -5.80) -- earnings

        • -1.2% HEIA.NA (Heineken €66.90, -0.82) -- sales

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Warehouses de Pauw (WDP.BB), Signify (LIGHT.NA)

        • Finland: Kemira (KEMIRA.FH), Hiab (HIAB.FH), Vaisala (VAIAS.FH), Terveystalo (TTALO.FH), Apetit (APETIT.FH), Loihde (LOIHDE.FH), Modulight (MODU.FH)

        • Germany: ATOSS Software (AOF.GR), Ringmetall (HP3A.GR)

        • Norway: Yara International (YAR.NO), Tomra Systems (TOM.NO), Kitron (KIT.NO), Norske Skog (NSKOG.NO), Vistin Pharma (VISTN.NO)

        • Sweden: Volvo (VOLV.B.SS), Electrolux (ELUX.B.SS), Beijer Alma (BEIA.B.SS), Telia Co. (TELIA.SS), Lifco (LIFCO.B.SS), Nordnet (SAVE.SS), Indutrade (INDT.SS), Svenska Cellulosa (SCA.B.SS), Castellum (CAST.SS), Mycronic (MYCR.SS), Betsson (BETS.B.SS), Xvivo Perfusion (XVIVO.SS), Alligo (ALLIGO.B.SS), Boozt Fashion (BOOZT.SS), Duni (DUNI.SS), CellaVision (CEVI.SS), Humana (HUM.SS), Midsona (MSON.B.SS), Nilörngruppen (NIL.B.SS), Netel Holding (NETEL.SS)

        • Switzerland: Kuehne & Nagel (KNIN.SW), Inficon Holding (IFCN.SW), BB Biotech (BION.SW)

        • Southern Europe: Eni (ENI.IM)

      • Trading Update:

        • Benelux: Flow Traders (FLOW.NA), ACOMO (ACOMO.NA), MotorK (MTRK.NA), Belysse Group (BELYS.BB)

        • DACHs: Holcim (HOLN.SW)

        • France: SPIE (SPIE.FP), Forvia (FRVIA.FP), Exel Industries (EXE.FP)

        • UK: Mondi (MNDI.LN), Record (REC.LN)

  • Data:

    • Economics:

      • UK

        • Apr CBI Industrial Trend Orders (38) vs consensus (34) and prior (27)

        • Mar Public Sector Net Borrowing £12.6B vs consensus £10.4B and prior revised £12.8B from £14.3B

      • Apr Flash Manufacturing PMI

        • Eurozone 52.2 vs consensus 50.8 and prior 51.6

        • UK 53.6 vs consensus 49.9 and prior 51.0

        • Germany 51.2 vs consensus 51.3 and prior 52.2

        • France 52.8 vs consensus 49.5 and prior 50.0

      • Apr Flash Services PMI

        • Eurozone 47.4 vs consensus 49.8 and prior 50.2

        • UK 52.0 vs consensus 50.0 and prior 50.5

        • Germany 46.9 vs consensus 50.3 and prior 50.9

        • France Apr Flash Services PMI 46.5 vs consensus 48.4 and prior 48.8

      • France Apr Business Survey 100 vs consensus 99 and prior 99

      • Norway Mar Unemployment Rate 4.9% vs consensus 4.9% and prior 4.9%

    • Markets:

      • WTI Crude (Jun 26): +$0.52 or +0.56% to $93.48

      • €-$ +0.0002 or +0.02% to 1.1710

      • £-$ (0.0003) or (0.02%) to 1.3501

      • €-£ +0.0003 to 0.8674

      • S&P 500 +0.09%

      • Performance year-to-date

        • FTSE 100: +5.29%

        • DAX: (1.37%)

        • CAC: +0.95%

        • MIB: +6.59%

        • Stoxx 600: +3.72%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.